Armata Pharmaceuticals (ARMP) Share-based Compensation Growth (1y) (2014 - 2026)
Armata Pharmaceuticals (ARMP) Share-based Compensation Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-69.95% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
0.18% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Armata Pharmaceuticals |
275.44 Mn |
270.68 Mn |
- |
37.64% |
| Date | Value |
|---|
| Mar 31, 2026 |
37.64% |
| Dec 31, 2025 |
78.53% |
| Sep 30, 2025 |
-7.16% |
| Jun 30, 2025 |
-56.93% |
| Mar 31, 2025 |
46.25% |
| Dec 31, 2024 |
83.42% |
| Sep 30, 2024 |
279.62% |
| Jun 30, 2024 |
411.49% |
| Mar 31, 2024 |
-37.69% |
| Dec 31, 2023 |
-76.38% |
| Sep 30, 2023 |
-144.09% |
| Jun 30, 2023 |
-72.50% |
| Mar 31, 2023 |
73.83% |
| Dec 31, 2022 |
23.04% |
| Sep 30, 2022 |
80.38% |
| Jun 30, 2022 |
4.63% |
| Mar 31, 2022 |
-41.45% |
| Dec 31, 2021 |
-22.97% |
| Sep 30, 2021 |
-29.26% |
| Jun 30, 2021 |
0.11% |
